How Much Did NutriSense Raise? Funding & Key Investors

NutriSense has successfully raised $25 million in a Series A funding round, backed by 13 investors including Davidovs Venture Collective and 1315 Capital. The company offers a metabolic health platform that combines real-time glucose monitoring with personalized dietitian coaching.

Keep reading to explore the intricacies of NutriSense's fundraising journey and the investors backing this innovative platform.

What Is NutriSense?

NutriSense, founded in 2019, operates in the health and wellness industry with a focus on personalized health insights and nutrition coaching. The company is based in Chicago, Illinois, and was founded by Alex Skyrl, Dan Zavorotny, and Kara Collier.

With an employee count ranging from 101 to 250, NutriSense leverages Continuous Glucose Monitors (CGMs) and machine learning technology to provide real-time glucose monitoring and personalized dietitian coaching. Their mission is to help individuals discover and reach their health potential through data-driven insights and expert guidance.

How Much Funding Has NutriSense Raised?

1. Pre-Seed Round
   • Amount Raised: Not publicly disclosed
   • Date: January 27, 2020
   • Lead Investors: Techstars
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To kickstart the company's operations and develop its initial product offerings.
2. Pre-Seed Round
   • Amount Raised: Not publicly disclosed
   • Date: July 27, 2020
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To further develop the product and prepare for market entry.
3. Funding Round
   • Amount Raised: $150,000
   • Date: September 18, 2020
   • Lead Investors: Techstars
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support early-stage growth and expand the team.
4. Seed Round
   • Amount Raised: $2.5 million
   • Date: October 30, 2020
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To scale operations and enhance product features.
5. Secondary Market
   • Amount Raised: Not publicly disclosed
   • Date: November 10, 2020
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To provide liquidity to early investors and employees.
6. Seed Round
   • Amount Raised: $3.8 million
   • Date: September 13, 2021
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand market reach and improve technology infrastructure.
7. Series A
   • Amount Raised: $25 million
   • Date: July 13, 2022
   • Lead Investors: 1315 Capital
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To drive continued growth, expand the operational team, and reach more consumers.

Total Amount Raised: $31.45 million. Current Valuation: Not publicly disclosed.

Key Investors

• 1315 Capital
  • Details: 1315 Capital is a private investment firm with nearly $900 million under management. They provide expansion and growth capital to commercial-stage healthcare services, medical technology, therapeutics, and pharmaceutical services companies.
  • Investment Focus Areas: Healthcare services, medical technology, therapeutics, pharmaceutical services.
  • Notable Investments: Not publicly disclosed.
• Davidovs Venture Collective
  • Details: Davidovs Venture Collective is an investment firm that focuses on early-stage companies. They aim to support innovative startups with the potential for significant growth.
  • Investment Focus Areas: Technology, healthcare, consumer products.
  • Notable Investments: Not publicly disclosed.
• Techstars
  • Details: Techstars is a global platform for investment and innovation. They run accelerator programs and provide funding to early-stage startups.
  • Investment Focus Areas: Technology, healthcare, consumer products, financial services, media.
  • Notable Investments: SendGrid, Sphero, DigitalOcean.

What's Next for NutriSense?

NutriSense stands at the cusp of significant growth opportunities. With the recent $25 million Series A funding, the company is poised to expand its operational team and reach a broader audience. The increasing demand for personalized health monitoring and the integration of real-time glucose data with dietitian insights present a vast market potential. As NutriSense continues to grow, future fundraising rounds are likely, potentially attracting more venture capital and strategic investments.

However, the path forward is not without challenges. NutriSense will need to navigate a competitive landscape, ensuring data privacy and maintaining service quality while scaling operations. The company must also stay ahead of regulatory requirements and technological advancements to sustain its growth trajectory. Despite these hurdles, NutriSense's innovative approach and strong financial backing position it well for continued success in the digital health sector.

Use Clay to Get Funding Data

Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like NutriSense and gather other critical business insights. Sign up for free to start enhancing your sales strategies today.